Camber Capital Management LP Immunovant, Inc. Transaction History

Camber Capital Management LP

  • $3.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$36.36 - $52.71 $16 Million - $23.1 Million
-438,800 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$22.61 - $38.9 $8.17 Million - $14.1 Million
-361,200 Reduced 45.15%
438,800 $15.4 Million
Q2 2020

Aug 14, 2020
BUY
$13.87 - $28.44 $11.1 Million - $22.8 Million
800,000 New
800,000 $19.5 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email